Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043282520> ?p ?o ?g. }
- W3043282520 endingPage "1133" @default.
- W3043282520 startingPage "1128" @default.
- W3043282520 abstract "Abstract Objective To estimate contemporary population‐based patterns of the relative burden of prostate cancer‐specific mortality (PCSM) attributable to each N0M0 prostate cancer risk‐group, that may guide prioritization in research, trial design, and clinical practice. Methods We categorized 2004‐2015 Surveillance, Epidemiology, and End Results database patients by risk group (low, favorable intermediate, unfavorable intermediate, high, and very highrisk). Using the Fine‐Gray method, we calculated the relative burden of 10‐year PCSM attributable to each risk group. Results Among N = 337 162 men (6.8‐year median follow‐up; median age 65 years), the relative proportion of low‐, favorable intermediate‐, unfavorable intermediate‐, high‐, and very high‐risk diagnoses were 29.9% ( N = 100 969), 31.1% ( N = 104 696), 17.9% ( N = 60 360), 18.1% ( N = 61 023), and 3.0% ( N = 10 114). Within 10 years of diagnosis, among patients who died of prostate cancer ( N = 15 064), 5.0% ( N = 746) had low‐risk, 13.7% ( N = 2060) had favorable intermediate‐risk, 16.1% ( N = 2429) had unfavorable intermediate‐risk, 47.8% ( N = 7196) had high‐risk, and 17.5% ( N = 2633) had very high‐risk disease at diagnosis. Patients aged 65 and older accounted for 51.9% of all diagnoses and 72.3% of 10‐year PCSM. Although black patients accounted for 15.0% of low‐risk diagnoses, they accounted for 20.6% of 10‐year PCSM. White patients accounted for 80.3% of low‐risk diagnoses and 75.7% of 10‐year PCSM. Conclusion Although high‐risk and very high‐risk disease account for one‐fifth of diagnoses, they account for two‐thirds of 10‐year PCSM. Older patients and black patients with low‐risk disease accounted for a disproportionately large proportion of deaths. These findings support targeting research toward high‐risk disease and ensuring adequate representation of older and black men in clinical trials." @default.
- W3043282520 created "2020-07-23" @default.
- W3043282520 creator A5001077235 @default.
- W3043282520 creator A5005203538 @default.
- W3043282520 creator A5008023764 @default.
- W3043282520 creator A5015096941 @default.
- W3043282520 creator A5041009458 @default.
- W3043282520 creator A5044221282 @default.
- W3043282520 creator A5056600997 @default.
- W3043282520 creator A5059789339 @default.
- W3043282520 creator A5064455342 @default.
- W3043282520 creator A5080270912 @default.
- W3043282520 date "2020-07-13" @default.
- W3043282520 modified "2023-10-01" @default.
- W3043282520 title "Prostate cancer‐specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities" @default.
- W3043282520 cites W1895094637 @default.
- W3043282520 cites W1986742341 @default.
- W3043282520 cites W2034244311 @default.
- W3043282520 cites W2043906346 @default.
- W3043282520 cites W2089198668 @default.
- W3043282520 cites W2118683350 @default.
- W3043282520 cites W2170133058 @default.
- W3043282520 cites W2197494872 @default.
- W3043282520 cites W2224702980 @default.
- W3043282520 cites W2342503198 @default.
- W3043282520 cites W2470255787 @default.
- W3043282520 cites W2529556796 @default.
- W3043282520 cites W2541684400 @default.
- W3043282520 cites W2560322684 @default.
- W3043282520 cites W2595559817 @default.
- W3043282520 cites W2611599104 @default.
- W3043282520 cites W2895262488 @default.
- W3043282520 cites W2900778010 @default.
- W3043282520 cites W2905488855 @default.
- W3043282520 cites W2911777256 @default.
- W3043282520 cites W2938747110 @default.
- W3043282520 cites W2946148461 @default.
- W3043282520 cites W2947745091 @default.
- W3043282520 cites W2949186437 @default.
- W3043282520 cites W2969978942 @default.
- W3043282520 cites W2982388316 @default.
- W3043282520 cites W3008584236 @default.
- W3043282520 cites W4251807134 @default.
- W3043282520 doi "https://doi.org/10.1002/pros.24041" @default.
- W3043282520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32659024" @default.
- W3043282520 hasPublicationYear "2020" @default.
- W3043282520 type Work @default.
- W3043282520 sameAs 3043282520 @default.
- W3043282520 citedByCount "13" @default.
- W3043282520 countsByYear W30432825202021 @default.
- W3043282520 countsByYear W30432825202022 @default.
- W3043282520 countsByYear W30432825202023 @default.
- W3043282520 crossrefType "journal-article" @default.
- W3043282520 hasAuthorship W3043282520A5001077235 @default.
- W3043282520 hasAuthorship W3043282520A5005203538 @default.
- W3043282520 hasAuthorship W3043282520A5008023764 @default.
- W3043282520 hasAuthorship W3043282520A5015096941 @default.
- W3043282520 hasAuthorship W3043282520A5041009458 @default.
- W3043282520 hasAuthorship W3043282520A5044221282 @default.
- W3043282520 hasAuthorship W3043282520A5056600997 @default.
- W3043282520 hasAuthorship W3043282520A5059789339 @default.
- W3043282520 hasAuthorship W3043282520A5064455342 @default.
- W3043282520 hasAuthorship W3043282520A5080270912 @default.
- W3043282520 hasConcept C107130276 @default.
- W3043282520 hasConcept C121608353 @default.
- W3043282520 hasConcept C126322002 @default.
- W3043282520 hasConcept C142724271 @default.
- W3043282520 hasConcept C2779134260 @default.
- W3043282520 hasConcept C2780192828 @default.
- W3043282520 hasConcept C2908647359 @default.
- W3043282520 hasConcept C29456083 @default.
- W3043282520 hasConcept C44249647 @default.
- W3043282520 hasConcept C534262118 @default.
- W3043282520 hasConcept C71924100 @default.
- W3043282520 hasConcept C82789193 @default.
- W3043282520 hasConcept C99454951 @default.
- W3043282520 hasConceptScore W3043282520C107130276 @default.
- W3043282520 hasConceptScore W3043282520C121608353 @default.
- W3043282520 hasConceptScore W3043282520C126322002 @default.
- W3043282520 hasConceptScore W3043282520C142724271 @default.
- W3043282520 hasConceptScore W3043282520C2779134260 @default.
- W3043282520 hasConceptScore W3043282520C2780192828 @default.
- W3043282520 hasConceptScore W3043282520C2908647359 @default.
- W3043282520 hasConceptScore W3043282520C29456083 @default.
- W3043282520 hasConceptScore W3043282520C44249647 @default.
- W3043282520 hasConceptScore W3043282520C534262118 @default.
- W3043282520 hasConceptScore W3043282520C71924100 @default.
- W3043282520 hasConceptScore W3043282520C82789193 @default.
- W3043282520 hasConceptScore W3043282520C99454951 @default.
- W3043282520 hasFunder F4320306080 @default.
- W3043282520 hasIssue "13" @default.
- W3043282520 hasLocation W30432825201 @default.
- W3043282520 hasLocation W30432825202 @default.
- W3043282520 hasOpenAccess W3043282520 @default.
- W3043282520 hasPrimaryLocation W30432825201 @default.
- W3043282520 hasRelatedWork W2024914724 @default.
- W3043282520 hasRelatedWork W2034630455 @default.
- W3043282520 hasRelatedWork W2152915862 @default.